Delisting riskPopularity #2,803
AKBA · NASDAQ · Biotechnology

Akebia Therapeutics (AKBA)

Markets kidney-disease medicines while advancing rare-renal and HIF programs.

$0.9750
After-hours close+0.00 (+0.13%)
At close$0.9737(+3.75%)
  1. New Strong Sell Stocks for April 28th

    Zacks Investment Research